Implantation of Implantable Cardioverter Defibrillators in Kazakhstan
References
- Barra S, Providência R, Tang A, Heck P, Virdee M, Agarwal S. Importance of Implantable Cardioverter-Defibrillator Back-Up in Cardiac Resynchronization Therapy Recipients: A Systematic Review and Meta-Analysis. J Am Heart Assoc. 2015; 4(11):
e002539 . Published 2015 Nov 6. DOI: 10.1161/JAHA.115.002539 - Akel T, Lafferty J. Implantable cardioverter defibrillators for primary prevention in patients with nonischemic cardiomyopathy: A systematic review and meta-analysis. Cardiovasc Ther. 2017; 35:
e12253 . DOI: 10.1111/1755-5922.12253 - Shun-Shin MJ, Zheng SL, Cole GD, Howard JP, Whinnett ZI, Francis DP. Implantable cardioverter defibrillators for primary prevention of death in left ventricular dysfunction with and without ischaemic heart disease: a meta-analysis of 8567 patients in the 11 trials. Eur Heart J. 2017; 38(22): 1738–1746. DOI: 10.1093/eurheartj/ehx028
- Al-Khatib SM, Stevenson WG, Ackerman MJ, et al. AHA/ACC/HRS guideline for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society. J. Am. Coll. Cardiol; 2017.
- Priori SG, Blomström-Lundqvist C, Mazzanti A, et al. Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC), 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: the Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC) endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Europace. 17 2015; 1601–1687.
- Higuera L, Holbrook R, Wherry K, et al. Comparison of cost effectiveness of implantable cardioverter defibrillator therapy in patients for primary prevention in Latin America: an analysis using the Improve SC; 2021. DOI: 10.1080/13696998.2021.1877451
- Holbrook R, Higuera L, Wherry K, et al. Implantable cardioverter defibrillator therapy is cost effective for primary prevention patients in Taiwan: An analysis from the Improve SCA trial. PLoS ONE. 2020; 15(11):
e0241697 . DOI: 10.1371/journal.pone.0241697 - Boriani G, Biffi M, Martignani C, Gallina M, Branzi A. Cost-effectiveness of implantable cardioverter-defibrillators. European Heart Journal. 2001; 22(12): 990–996. DOI: 10.1053/euhj.2000.2371
- Basu-Ray I, Liu J, Jia X, et al. Subcutaneous Versus Transvenous Implantable Defibrillator Therapy: A Meta-Analysis of Case-Control Studies. JACC Clin Electrophysiol. 2017 Dec 26; 3(13): 1475–1483. DOI: 10.1016/j.jacep.2017.07.017
- Government of the Republic of Kazakhstan.
State Healthcare Development Program, ‘Densaulyk’ for 2016–2019 . Approved Government Decree No. 634. Astana: October 15, 2018.http://adilet.zan.kz/rus/docs/P1800000634 . (Accessed 13 January 2022). - Kulzhanov M, Rechel B.
Kazakhstan: health system review . Copenhagen: World Health Organization. Regional Office for Europe. 2007.https://apps.who.int/iris/handle/10665/107868 . (Accessed 13 January 2022). - Boveda S, Lenarczyk R, Haugaa K, et al. Implantation of subcutaneous implantable cardioverter defibrillators in Europe: results of the European Heart Rhythm Association survey. Europace. 2016 Sep; 18(9): 1434–9. DOI: 10.1093/europace/euw258
- Lee JH, Lee SR, Choi EK, et al. Temporal Trends of Cardiac Implantable Electronic Device Implantations: a Nationwide Population-based Study. Korean Circ J. 2019 Sep; 49(9): 841–852. DOI: 10.4070/kcj.2018.0444
- Greenspon AJ, Patel JD, Lau E, et al. 16-year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008. J Am Coll Cardiol. 2011 Aug 30; 58(10): 1001–6. DOI: 10.1016/j.jacc.2011.04.033
- Pekka Raatikainen MJ, Arnar DO, Zeppenfeld K, Jose Luis Merino JL, Kuck K-H, Hindricks G. Current trends in the use of cardiac implantable electronic devices and interventional electrophysiological procedures in the European Society of Cardiology member countries: 2015 report from the European Heart Rhythm Association. EP Europace. 2015 August; 17(4): iv1–iv72. DOI: 10.1093/europace/euv265
- Lozano IF, Asensi JO, Rodríguez JA, Spanish Implantable Cardioverter-defibrillator Registry. 16th Official Report of the Heart Rhythm Association of the Spanish Society of Cardiology (2019). Rev Esp Cardiol. 2020; 73(12): 1026–1037.
https://www.revespcardiol.org/en-spanish-implantable-cardioverter-defibrillator-registry-16th-articulo-S1885585720304011 . DOI: 10.1016/j.rec.2020.07.015 - Barra S, Providência R, Paiva L, Heck P, Agarwal S. Implantable cardioverter-defibrillators in the elderly: rationale and specific age-related considerations. Europace. 2015 Feb; 17(2): 174–86. DOI: 10.1093/europace/euu296
- Lin G, Meverden RA, Hodge DO, Uslan DZ, Hayes DL, Brady PA. Age and gender trends in implantable cardioverter defibrillator utilization: a population based study. J Interv Card Electrophysiol. 2008; 22(1): 65–70. DOI: 10.1007/s10840-008-9213-6
- Foo FS, Lee M, Looi K-L, et al.; on behalf of the ANZACS-QI investigators. Implantable cardioverter defibrillator and cardiac resynchronization therapy use in New Zealand (ANZACS-QI 33). J Arrhythmia. 2020; 36: 153–163. DOI: 10.1002/joa3.12244
- Ezzat VA, Lee V, Ahsan S, et al. A systematic review of ICD complications in randomised controlled trials versus registries: is our ‘real-world’ data an underestimation? Open Heart. 2015; 2(1):
e000198 . Published 2015 Feb 17. DOI: 10.1136/openhrt-2014-000198 - Chao TF, Lai CH, Tuan TC, et al. Long-Term Prognosis in Recipients of Implantable Cardioverter-Defibrillators for Secondary Preventions in Taiwan – A Multicenter Registry Study. Acta Cardiol Sin. 2014; 30(1): 22–28.
DOI: https://doi.org/10.5334/gh.1119 | Journal eISSN: 2211-8179
Language: English
Submitted on: May 3, 2021
Accepted on: Apr 16, 2022
Published on: May 10, 2022
Published by: Ubiquity Press
In partnership with: Paradigm Publishing Services
Publication frequency: 1 issue per year
Keywords:
© 2022 Temirkhan Begisbayev, Lyazzat Kosherbayeva, Valikhan Akhmetov, Dmitry Khvan, Marzhan Brimzhanova, published by Ubiquity Press
This work is licensed under the Creative Commons Attribution 4.0 License.